2 active not recruiting, 2 recruiting. 3 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Benjamin Tomlinson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant Venetoclax, Decitabine - Myeloid Malignancy, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Recruiting | Benjamin Tomlinson | 20 | 2025-07-28 | 2026-10-08 |
| Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies Fully human anti CD19 CAR-T Cell Dose, Fludarabine, Cyclophosphamide - Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | Active not recruiting | Benjamin Tomlinson | 18 | 2021-04-26 | 2026-09-23 |
| 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies 5-azacytidine, Decitabine - Myelodysplastic Syndromes, MDS/MPN Crossover Syndromes | Early Phase 1 | Recruiting | Benjamin Tomlinson | 20 | 2020-11-16 | 2026-05-18 |
| AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma Cyclophosphamide, Fludarabine, CAR-T Cells - Non-Hodgkin Lymphoma | Phase 1 | Active not recruiting | Benjamin Tomlinson | 31 | 2018-07-09 | 2026-02-27 |
Lymphoma, Non-Hodgkin (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Cyclophosphamide (2) · Decitabine (2) · fludarabine (2) · fludarabine phosphate (2) · Azacitidine (1) · Immunotherapy, Adoptive (1) · venetoclax (1)
United States (4)
Benjamin H Tomlinson, Tomlinson (1) · Claudio Brunstein, MD, PhD (1) · James Ignatz-Hoover, MD, PhD (1)